Pulmotect, Inc.
  • Home
  • About Us
    • Our Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Our Approach
    • Overview
    • Our Science
    • Our Pipeline
    • Published Journal Articles
  • News
  • Contact Us

Pulmotect Seeks Quick-To-Market Path For Rapid-Acting Respiratory Drug

Posted on June 28, 2017July 6, 2017 by Brenton Scott
Posted in News Coverage

Post navigation

Telephus Medical CEO Mark Benedyk Joins Pulmotect, Inc. Board of Directors
Pulmotect Announces Initial Close on $12 Million Series B
Pulmotect Inc

3900 Essex Ln, Suite 575
Houston, TX 77027
Contact Us

© 2025
Pulmotect, Inc.